NCT07259369Completed
The Effects of an App-based Acupressure on Alleviating Fatigue, Pruritus, and Sleep Quality Among Hemodialysis Patients
The Effects of an App-based Acupressure Intervention on Alleviating Fatigue, Pruritus, and Sleep Quality Among Hemodialysis Patients
Source: ClinicalTrials.gov · Last updated 29 Oct 2026
Brief summary (registry, in English)
Objectives: To evaluate the effectiveness of an app-based self-guided acupressure intervention in alleviating fatigue and pruritus, and in improving sleep quality among hemodialysis patients. Design and subjects: The parallel randomized controlled trial will be employed in one hospital. Block randomization in a 1:1 ratio will be used to assign the patients to the intervention and control groups. It is estimated that 50 to 100 participants receiving hemodialysis will be recruited. Instrument: The demographic and health-related information questionnaire, the Post-dialysis Fatigue, 5-D Itch, and Pittsburgh Sleep Quality Index will be used in this study. Interventions: The intervention group will use an app-based self-guided acupressure program to do the acupressure by themselves once daily for 4 weeks. Participants in the control group will receive usual care and no other intervention. Data analysis: Both intention-to-treat and per-protocol analysis approaches will be performed. Generalized Estimating Equations analysis will be used to assess the effectiveness of the interventions. Sensitivity analysis will be conducted to assess the impact of missing data on the treatment effect if necessary. Expected outcomes: Participants in the intervention group will know how to do the self-guided acupressure by themselves. If the intervention is effective, the App can be introduced to the hemodialysis patients who need it.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 17 Nov 2025
- Start date
- 15 Dec 2025
- Primary completion date
- 15 May 2026
- Lead sponsor
- Taipei Medical University
- Diseases
- Chronic kidney disease
- NCT number
- NCT07259369
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 15 Dec 2025 to the primary completion date, 15 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- 18 years old or over
- are able to speak and understand Vietnamese,
- receive hemodialysis at least three times a week for three months or longer
- have a score equal to or greater than 4 on a numeric rating scale (NRS, 0-10)
- has a smartphone or tablet
- can provide written informed consent. Exclusion Criteria: The patients who have
- advanced cancer
- cognitive impairment
- chronic obstructive pulmonary disease
- severe edema
- have already used or plan to use acupressure or acupuncture in the following 3 months
- have soft tissue or vascular disease in their lower extremities
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hoe Nhai General Hospital Coordinator of this site? Confirm its status | Hanoi | Vietnam | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.